User contributions for OncoMedSci
A user with 10 edits. Account created on 19 June 2020.
1 July 2020
- 11:2211:22, 1 July 2020 diff hist +3,436 m Prostate cancer added some references and links, and a couple of sentences on PIM & MRI. Tag: Visual edit
25 June 2020
- 21:0521:05, 25 June 2020 diff hist +1,228 m Cobimetinib →History: Added a sentence with refs and links on pre-clinical investigations of this drug. Tag: Visual edit
- 21:0121:01, 25 June 2020 diff hist +2,036 MEK inhibitor Added a subsection on pre-clinical development of MEK inhibitors, with links and citations, as this was a notable omission. Tag: Visual edit
- 20:5420:54, 25 June 2020 diff hist +1,210 m Mitogen-activated protein kinase →As therapeutic targets: Added one line with citations and links regardings MEK co-targeting. Tag: Visual edit
- 20:3120:31, 25 June 2020 diff hist +4,150 m Cancer treatment →Targeted therapies: Added one sentence on more recent advances in pre-clinical targeted therapy development, with appropriate citations and links. Tag: Visual edit
- 20:1920:19, 25 June 2020 diff hist +876 m ERG (gene) →Cancer: added recent peer reviewed paper on ERG targeting in prostate cancer Tag: Visual edit
19 June 2020
- 11:5311:53, 19 June 2020 diff hist +3,601 m Phosphoinositide 3-kinase →PI3K inhibitors as therapeutics: added a referenced point about co-targeting & resistance. Tag: Visual edit
- 11:4711:47, 19 June 2020 diff hist +1,238 m PI3K/AKT/mTOR pathway →PI3K pathway co-targeted therapy: Add two recent reviews on co-targeting PI3K and PIM Tag: Visual edit
- 11:4311:43, 19 June 2020 diff hist +1,070 m PIM2 (gene) added 2 recent reviews on PIM targeting in cancer Tag: Visual edit
- 11:4111:41, 19 June 2020 diff hist +3,559 m PIM1 Added a little more detail on Pim-1 targeting and co-targeting in cancer, referencing two recent peer reviewed reviews on the topic. Tag: Visual edit
